IBM is stopping development and sales of its tool that utilizes Watson AI to help pharmaceutical companies find new drugs, according to a STAT report. A source told STAT that the product, Watson for ...

On Thursday, STAT published a story claiming that IBM is halting sales of Watson for Drug Discovery — a service that uses the company’s Watson AI to analyze connections between genes, drugs, and ...

IBM has discontinued the development and sales of its Watson for Drug Discovery product due to poor financial performance, according to STAT. This usage of IBM's Watson artificial intelligence ...

Door closes on drug discovery. IBM is tapering off sales of its Watson for Drug Discovery product in favor of other healthcare offerings using the AI technology, STAT reported this morning. The ...

Improved cognitive computing by the supercomputer has accelerated the pace of scientific breakthroughs by discovering previously unknown connections in Big Data. Available now as a cloud service, ...

Responding to reports that it will no longer sell its Watson artificial intelligence system for use in drug discovery, IBM says it is “not discontinuing our Watson for Drug Discovery offering” and ...

As the AI hype-cycle has built, we've been treated to a plethora of claims about what sorts of improvements and breakthroughs the technology can deliver. One of the most fundamental -- and potentially ...

IBM is ending new sales its Watson programs aimed at artificial intelligence-based drug discovery and development due to poor financial returns, according to a report from Stat. The news follows Big ...